Weekly, paclitaxel plus carboplatin in patients with metastatic transitional cell carcinoma of the urothelium who failed MVAC: Phase II trial

被引：0
|
作者：
Kouno, T. [1 ]
Ando, M. [1 ]
Yonemori, K. [1 ]
Matsumoto, K. [1 ]
Komiyama, M. [1 ]
Okajima, E. [1 ]
Matsuoka, N. [1 ]
Fujimoto, H. [1 ]
Fujiwara, Y. [1 ]
机构：
[1] Natl Canc Ctr, Div Med Oncol, Tokyo, Japan
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial
    Proto, C.
    Manglaviti, S.
    Galli, G.
    Imbimbo, M.
    Alvisi, M. F.
    Zollo, F.
    Perrino, M. R. A.
    Giuliano, M.
    Pietroluongo, E.
    Ballatore, Z.
    Chella, A.
    Fabbri, A.
    Vigorito, R.
    De Braud, F. G. M.
    Pasello, G.
    Petrini, I.
    Berardi, R.
    Zucali, P. A.
    Ganzinelli, M.
    Garassino, M. C.
    Lo Russo, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S1337 - S1337
  • [22] Phase II Trial of Carboplatin and Paclitaxel in Papillary Renal Cell Carcinoma
    Bylow, Kathryn A.
    Atkins, Michael B.
    Posadas, Edwin M.
    Stadler, Walter M.
    McDermott, David F.
    CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 39 - 42
  • [23] Weekly Paclitaxel as Third-line Chemotherapy in Patients With Metastatic Transitional Cell Carcinoma of Urothelial Tract: Results of a Phase II Study
    Rozzi, A.
    Nardoni, C.
    Corona, M.
    Falbo, T.
    De Marco, F.
    Grillenzoni, L.
    Lanzetta, G.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S518 - S518
  • [24] Phase II trial of paclitaxel (T) and carboplatin (C) in patients with recurrent or metastatic cervical carcinoma.
    Kitagawa, R
    Katsumata, N
    Yamanaka, Y
    Ando, M
    Fujiwara, Y
    Kasamatsu, T
    Onda, T
    Yamada, T
    Tsunematsu, R
    Watanabe, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 461S - 461S
  • [25] Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features
    Shannon, C
    Crombie, C
    Brooks, A
    Lau, H
    Drummond, M
    Gurney, H
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 947 - 952
  • [26] Weekly dose-dense paclitaxel and carboplatin in recurrent ovarian carcinoma: A phase II trial
    Shawky, Hanan
    Tawfik, Hesham
    Hewidy, Medhat
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2014, 26 (03) : 139 - 145
  • [27] Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial
    CC Zielinski
    B Schnack
    M Grbovic
    T Brodowicz
    C Wiltschke
    G Steger
    H Pflüger
    M Marberger
    British Journal of Cancer, 1998, 78 : 370 - 374
  • [28] Phase I trial of paclitaxel, cisplatin, and gemcitabine (TCG) in patients (p) with advanced transitional cell carcinoma (TCC) of the urothelium
    Bellmunt, J
    Baselga, J
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 140 - 140
  • [29] Paclitaxel and carboplatin in patients with metastatic urothelial cancer:: Results of a phase II trial
    Zielinski, CC
    Schnack, B
    Grbovic, M
    Brodowicz, T
    Wiltschke, C
    Steger, G
    Pflüger, H
    Marberger, M
    BRITISH JOURNAL OF CANCER, 1998, 78 (03) : 370 - 374
  • [30] RANDOMIZED PHASE-II EVALUATION OF CARBOPLATIN AND CHIP IN ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM
    TRUMP, DL
    ELSON, P
    MADAJEWICZ, S
    DICKMAN, SH
    HAHN, RG
    HARRIS, JE
    VOGL, SE
    JOURNAL OF UROLOGY, 1990, 144 (05): : 1119 - 1122
12345